Back
The Estee Lauder Companies Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Sell
45
EL
The Estee Lauder Companies
Last Price:
113.74
Seasonality Move:
-2.31%
Sell
38
RARE
Ultragenyx Pharmaceutical
Last Price:
39.58
Seasonality Move:
3.65%
Sell
45
The Estee Lauder Companies (EL)
is a Sell
Is The Estee Lauder Companies a Buy, Sell or Hold?
- The current The Estee Lauder Companies [EL] share price is $112.70. The Score for EL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- EL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $38.02. The Score for RARE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EL Stock Price Chart
What is The Estee Lauder Companies's stock price today?
-
The The Estee Lauder Companies share price today is $112.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EL is experiencing buying pressure, which is a positive indicator for future bullish movement.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $38.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.
EL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -5.47 | Sell |
| Relative Strength Index (14 RSI): | 29.89 | Sell |
| Chaikin Money Flow: | 2969703 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (115.67 - 130.71) | Sell |
| Bollinger Bands (100): | (127.24 - 149.72) | Sell |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.74 | Sell |
| Relative Strength Index (14 RSI): | 40.05 | Sell |
| Chaikin Money Flow: | 76134 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.06 - 42.34) | Sell |
| Bollinger Bands (100): | (41.13 - 48.85) | Sell |
EL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 114.6 | Sell |
| 20-day SMA: | 120.34 | Sell |
| 50-day SMA: | 131.13 | Sell |
| 200-day SMA: | 137.31 | Sell |
| 8-day EMA: | 114.9 | Sell |
| 20-day EMA: | 120.04 | Sell |
| 50-day EMA: | 128.29 | Sell |
| 200-day EMA: | 145.76 | Sell |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 40.68 | Sell |
| 20-day SMA: | 40.48 | Sell |
| 50-day SMA: | 42.18 | Sell |
| 200-day SMA: | 42.45 | Sell |
| 8-day EMA: | 39.81 | Sell |
| 20-day EMA: | 40.64 | Sell |
| 50-day EMA: | 42.13 | Sell |
| 200-day EMA: | 43.5 | Sell |
The Estee Lauder Companies Earnings Growth & EL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.96 per share, a decrease next quarter of $0.23 per share, a decrease this year of $1.11 per share, and an increase next year of $1.91 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.
The Estee Lauder Companies Technical Analysis
| Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | 18 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||